The customer complained of erroneous results for 1 patient tested for elecsys tsh assay (tsh), elecsys ft3 iii (ft3 iii) and elecsys ft4 ii assay (ft4 ii) on a cobas 8000 e 602 module.This medwatch will cover ft4 ii.Refer to medwatch with (b)(6) for information on the tsh erroneous results and medwatch with (b)(6) for information on the ft3 iii erroneous results.The patient is a (b)(6) who had a tsh result of 700 uiu/ml at birth and was administered an unspecified amount of thyradin (levothyroxine sodium hydrate) for treatment.On (b)(6) 2017 the patient¿s thyradin dose was decreased since her hormone levels were slightly higher.On (b)(6) 2017 the patient¿s hormone level was very high and auto-antibody testing was ordered.Based on the results, the physician has excluded graves¿ disease and subacute thyroiditis.There was no allegation that an adverse event occurred.The e602 module serial number was (b)(4).
|
A specific root cause was not identified.Based on the available data, a general reagent issue could be excluded.There was not enough sample volume left to complete the investigation.Possible root causes of the discrepant results relate to the following: assays from different manufacturers can generate different results.This relates to the differences in how the assay is set up, the antibodies used and the standardization/methodology used.The changing results for the tsh, ft3 iii and ft4 ii over time, independent of the type of analyzer used, may have been caused by the changing doses of thyradin (levothyroxine) and the overall clinical condition of the patient.The differences in the ft3 iii and ft4 ii results between the different analyzers may be due to a biological component in the sample that interacts differently with components of the assays for both manufacturers; however, confirmation of this is not possible since there was not enough sample left to complete the investigation.
|